PharmiWeb.com - Global Pharma News & Resources
15-Jan-2021

Regenerative Therapies Market Size to Expand at Highest Revenue US$ 45,940.7 Million by 2027, Owing to Rapid Growth of Stem Cell Businesses

Global Regenerative Therapies Market

Regenerative therapy involve replacing, engineering or regenerating human or animal cells for the treatment of various diseases.  It finds application in soft tissue repair and the treatment of cardiovascular, dental, orthopedic, and central nervous system (CNS) diseases.

Statistics:

The global regenerative therapies market is estimated to account for US$ 45,940.7 Mn in terms of value by the end of 2027.

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/3712

Global Regenerative Therapies Market: Drivers

Increasing funding R&D in regenerative therapies is expected to propel growth of the global regenerative therapies market over the forecast period. For instance, in April 2020, Cellphire, Inc., a developer of cell stabilization technology for application in targeted drug delivery and regenerative medicine, received US$ 33.3 million contract from the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, to support Cellphire’s next generation platelet-based hemostatic products.

Moreover, increasing waiting list for organ transplant is also expected to aid in growth of the market. For instance, according to the U.S. Government Information on Organ Donation and Transplantation, over 112,000 patients are on the national transplant waiting list as of March 2020.

Market Opportunities

R&D in regenerative therapies is expected to offer lucrative growth opportunities for players in the global regenerative therapies market. For instance, in April 2020, researchers from University of Teramo, Italy, reported assessing whether endocannabinoid system is involved in tuning the constitutive and lipopolysaccharide-induced ovine amniotic epithelial cells anti-inflammatory and pro-inflammatory interleukin profiles.

Players in the market can also focus on adopting nanotechnology in development of novel regenerative therapies. Silver nanoparticle-coated porous titanium implants have shown effective bone formation and osseointegration in several studies.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3712

Market Restraints

Recall of products is expected to hinder growth of the market. For instance, in October 2018, Liveyon, the U.S.-based company, was issues U.S. FDA recall for its Liveyon ReGen product series, owing to adverse reactions.

Key Takeaways:

The global regenerative therapies market was valued at US$ 10,421.5 Mn in 2019 and is forecast to reach US$ 45,940.7 Mn by 2027 at a CAGR of 20% between 2020 and 2027. Increasing funding R&D in regenerative therapies is expected to propel growth of the global regenerative therapies market over the forecast period.

Allograft segment held dominant position in the global regenerative therapies market in 2019, accounting for 57.7% share in terms of value, followed by xenograft and alloplast, respectively. Increasing use of allograft as a biological regenerative material is expected to propel the growth of the segment.

Market Trends/Key Takeaways

Increasing government spending on regenerative therapies is expected to aid in growth of the market. For instance, in March 2018, the U.S. government offered US$ 37 billion for the National Institutes of Health, which includes US$ 10 million in funding for regenerative medicine research.

Cadaver Stem Cells (CSCs) is an innovative option in the near future for regenerative therapies. The isolation of viable and functional CSCs from humans even after several days of post-mortem is possible today. Many sites of cadaver donors could be suitable for CSCs obtention. Heparinized cadaveric multiple organ donors are an important source of organs and tissue for transplant therapies.

Global Regenerative Therapies Market: Competitive Landscape  

Major players operating in the global regenerative therapies market include, Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Nuo Therapeutics (Cytomedix Inc.), Advanced Cell Technology, Inc., BioStem Life Sciences, Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., and Cytori Therapeutics, Inc.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/regenerative-therapies-market-3008

Global Regenerative Therapies Market: Key Developments 

January 2020: Akron Biotechnology published a white paper proposing a new pragmatic, unified and staged approach for the qualification of ancillary materials for the manufacture of Advanced Therapy Medicinal Products

December 2019: Pluristem Therapeutics Inc. enrolled 75% of the 246 patients planned for its Phase III clinical study of PLX-PAD in the treatment of Critical Limb Ischemia

Taxonomy (Scope, segments)

  • By Tissue Type
    • Allograft
    • Xenograft
    • Alloplast
  • By Application
    • Soft Tissue Repair
    • Cardiovascular
    • Dental
    • Orthopedic
    • CNS disease treatment
    • Others
  • By End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Educational Institutes
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 15-Jan-2021